A Randomized, Investigator-Masked, Double-Blind, Placebo-Controlled Trial on Thalidomide in Severe Cutaneous Sarcoidosis

References

Page 1

	Year	Citations
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. E P Sampaio, Euzenir Nunes Sarno, Ruth Galilly, The Journal of Experimental Medicine Toxic EffectsImmune RegulationImmunologyCell DeathPathology	1991	1.2K
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. André L. Moreira, E P Sampaio, A Zmuidzinas, The Journal of Experimental Medicine ApoptosisImmunologyCell DeathPathologyPharmacotherapy	1993	1.1K
Medical progress:sarcoidosis EN Li-ping, Pumc Hospita Zhonghua linchuang mianyi he biantai fanying zazhi	2008	719
Improved Discriminative and Evaluative Capability of a Refined Version of Skindex, a Quality-of-Life Instrument for Patients With Skin Diseases Mary‐Margaret Chren Archives of Dermatology	1997	474
Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases Mery Margaret Chren Archives of Dermatology Refined VersionEvaluative CapabilitySkin DiseasesClinical DermatologyWound Healing	1997	446
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial Marc A. Judson, Robert P. Baughman, Ulrich Costabel, European Respiratory Journal	2008	319
The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures Sheena McHugh, Ian R. Rifkin, John Deighton, Clinical & Experimental Immunology	1995	263
Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Robert P. Baughman, Elyse E. Lower, Deborah Bradley, PubMed	2005	194
Thalidomide for Chronic Sarcoidosis Robert P. Baughman, Marc A. Judson, Alvin S. Teirstein, CHEST Journal RheumatologyThrombosisMedicinePharmacotherapyClinical Disease	2002	193
Incidence and Risk Factors for Thalidomide Neuropathy: a Prospective Study of 135 Dermatologic Patients Sylvie Bastuji‐Garin, S. Ochonisky, P. Bouché, Journal of Investigative Dermatology Dermatologic PatientsNeuroepidemiologyThalidomide NeuropathyDermatologyNeuropathology	2002	183

Page 1